Prof. Luigi Chiariello
ACADEMIC POSITION
– Full Professor of Cardiac Surgery, Chair of Cardiac Surgery, Tor Vergata University of Rome
– Director, Residency Program in Cardiac Surgery, Tor Vergata University of Rome
– President, Course Degree in Techniques of Cardiovascular Pathophysiology and Cardiovascular Perfusion, Tor Vergata University of Rome
Main Fields of Surgical Activity:
– Coronary artery disease and surgical revascularization (coronary artery bypass grafting)
– Heart valve repair surgery
– Surgery of aneurysms of the aortic root and ascending aorta
– Percutaneous endovascular treatment of descending thoracic aortic aneurysms
– Simultaneous Hybrid Revascularization of Carotid and Coronary Artery Atherosclerotic Disease
– Surgery of Heart Failure
Fields of Active Research:
– Prevention and treatment of sternal dehiscence in cardiac surgery
– Anticoagulant treatment in the immediate postoperative period in patients subjected tovalve replacement with a bioprosthetic valve
– Reduction of the effects of inflammation on restenosis after stent implantation
– New method of cerebral perfusion during circulatory arrest for aortic arch surgey
– Dexamethasone administration for prevention of restenosis after PTCA procedures
– Evaluation of long-term results of surgical repair and replacement of the aortic root, of surgical treatment of the heart failure and of surgical repair of the mitral valve
– Role of non-invasive diagnostic tools (cardiac CT) in cardiac surgery
– Techniques of miniaturized extracorporeal circulation (mecc)
International clinical trials:
– SHARP
Simultaneous Hybrid Revascularization by Carotid Stenting and Coronary Artery Bypass Grafting trial.
Multicenter trial (Policlinico Tor Vergata, Rome, Italy, Civil Hospital, Mirano, Italy, Heart Center, Hamburg, Germany) on simultaneous hybrid revascularization with internal carotid artery stenting and coronary artery bypass surgery.
– STICH
Surgical Treatment for Ischemic Heart Failure: Multicenter international trial (Europe, Asia, America).
– RED-CABG Trial. Effect of intracoronary acadesine admnistration for cardioplegic protection during coronary artery bypass surgery with extracorporeal circulation. Shering-Plough EU Acadesine (RED-CABG Trial). Principal Investigator Luigi Chiariello, Tor Vergata University of Rome. Time of the study: October 2009-August 2010.
National clinical trial
Observant Study. Observational study to assess the appropriateness, efficiency and effectiveness of the AVR-TAVI in the treatment of aortic stenosis. National Institute of Health. Principal Investigator University of Rome Tor Vergata: Luigi Chiariello. Duration of the study: January 2011-June 2012. Policlinico Tor Vergata.
– University “intra moenia” Seminars of the Residency Program in Cardiac Surgery with the participation of teachers from the University of Tor Vergata and other Italian and European Universities, to address the most innovative diagnostic and therapeutic cardiovascular issues.
Topics of research carried out by means of multi-center trials:
1) simultaneous hybrid revascularization of coronary and carotid district
2) surgical treatment of heart failure using geometric reconstruction of the left ventricle and coronary artery bypass grafting